ArticleActa pharmaceutica Sinica. B2026
Discovery of novel tumor-targeting peptide-oncolytic peptide based conjugates (PPCs): A new paradigm for targeted oncolytic-immunotherapy.
Qianyao Yu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.